8--611--11-4--5-5612- 8-CHLORO-611-DIHYDRO-11-4-PIPERIDYLIDENE-5H-BENZO56CYCLOHEPTA12-bPYRIDINE ORAL COMPOSITIONS

摘要

In the present invention, 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5H-benzo [5,6] cyclohepta [1,2-b] pyridine { Hereinafter, " DCL "} , And a pharmaceutically acceptable basic salt (e.g., dibasic calcium phosphate) in an amount sufficient to effectively protect DCL and about 80% or more by weight of the pharmaceutical composition in about 45 minutes Suitable for treating allergic reactions in mammals (e.g., humans), comprising a sufficient amount of one or more disintegrants (preferably two disintegrants such as microcrystalline cellulose and starch) A stable pharmaceutical composition for oral administration is provided.